SCHEMBL19904368

SCHEMBL19904368

O=C(NC(Cc1cc(F)c2c(c1)OCCO2)CN1CCCCC1)C1CCN(c2ccc(Cl)cc2)C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 1/20 0.38
KMT2A Q03164 1/20 0.38
NOTUM Q6P988 2/20 0.38
CCR1 P32246 1/20 0.36
USP2 O75604 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HSD17B10 Q99714 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
DRD2 P14416 1/20 0.35
DRD3 P35462 1/20 0.35
PROKR2 Q8NFJ6 1/20 0.35
UGCG Q16739 1/20 0.34
PDCD1 Q15116 1/20 0.34
CD274 Q9NZQ7 1/20 0.34
KDM4E B2RXH2 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19904551 1.00 HTR1A (0.38) HTR1AKMT2ANOTUMCCR1USP2
SCHEMBL19904427 0.99 KMT2A (0.38) HTR1AKMT2ANOTUMCCR1USP2
SCHEMBL19904488 0.98 KMT2A (0.38) HTR1AKMT2ANOTUMCCR1USP2
SCHEMBL19904389 0.93 UGCG (0.40) HTR1AKMT2ANOTUMUSP2ALDH1A1
SCHEMBL19904542 0.93 UGCG (0.40) HTR1AKMT2ANOTUMUSP2ALDH1A1
SCHEMBL19904455 0.91 KMT2A (0.36) HTR1AKMT2ANOTUMALDH1A1MAPK1
SCHEMBL19904590 0.91 KMT2A (0.36) HTR1AKMT2ANOTUMALDH1A1MAPK1
SCHEMBL19904506 0.89 TRPV1 (0.39) HTR1ANOTUMUSP2ALDH1A1HPGD
SCHEMBL19904487 0.88 KMT2A (0.48) HTR1AKMT2ANOTUMCCR1USP2
SCHEMBL19904430 0.88 KMT2A (0.48) HTR1AKMT2ANOTUMCCR1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3063141-B1 N-(1-HYDROXY-3-(PYRROLIDINYL)PROPAN-2-YL)PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS BIOMARIN PHARM INC (US) 2018-02-28 EP disclosed